openPR Logo
Press release

Global Fragile X Syndrome Market 2027: Top Key Players Marinus pharmaceuticals, Ovid therapeutics, Kareus Therapeutics, Bellus health Inc., AMO pharmaceuticals, Eli Lilly & Company, Neuren pharmaceuticals, Anavex Life Sciences Corp., and Zynerba Pharmaceu

03-04-2019 07:21 AM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd.

Fragile X syndrome is a hereditary condition that causes a range of neurological problems including cognitive impairment and learning disabilities. Males are more affected compare to females by this disorder. It causes delayed development of speech and language by age 2. Affected children may develop attention deficit disorder; about one-third individual may develop autism, and in about 15% of male and 5% of female seizure occurs. Most males and about half of females with fragile X syndrome have characteristic physical features that become more prominent with age. These features include large ears, a long and narrow face, unusually flexible fingers, flat feet, a prominent jaw and forehead, and in males, enlarged testicles after puberty. It is estimated that approximately 1 in 2500-4000 males and 1 in 7000-8000 females.

Request For Sample @ https://bit.ly/2VzpB42

The global Fragile X syndrome market is segmented on the basis of treatment and geography. On the basis of treatment the global Fragile X syndrome is further segmented into sedatives, muscle relaxants, antipsychotics, and other. Currently there is no approved treatment for Fragile X Syndrome, however treatment and intervention are focused to improve lives of affected individuals. Majority of pipeline molecules (gaboxadol, etc.) for the treatment of Fragile X Syndrome are currently in phase 2 of development are expected to come into the market in forecast period. Increase in incidence and prevalence of Fragile X Syndrome expected to boost the growth of the market in forecast period. In addition to it, ongoing clinical trials and growing licensing and acquisition deals will further drives the growth of the market. However, stringent government regulation, complex disease mechanism, and disappointing results of promising pipeline molecules hampers the growth of the Fragile X syndrome market during forecast period. Furthermore, lack of awareness among people regarding genetic disorders restrains the growth of the market.

At regional level, the global Fragile X syndrome market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In terms of revenue, North America followed by Europe is major contributor for the global Fragile X syndrome market. This is because strong clinical pipeline, increasing research and drug development activities, presence of major players, and presence of developed healthcare infrastructure propels the growth of the market in the region. Asia Pacific is third promising revenue contributor which is expected to grow at rapid pace in upcoming year. Countries such as Japan, India and China are major contributors for this market. Emerging and huge population base countries such as China and India offers tremendous market opportunities for the Fragile X syndrome market.

Request For Table Of Content (TOC) @ https://bit.ly/2VzpB42

Some of the market players leading the global Fragile X syndrome market include Marinus pharmaceuticals, Ovid therapeutics, Kareus Therapeutics, Bellus health Inc., AMO pharmaceuticals, Eli Lilly & Company, Neuren pharmaceuticals, Anavex Life Sciences Corp., and Zynerba Pharmaceuticals, Inc.

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products.

Contact Us:
Mr. John Smith
InsightAce Analytic Pvt. Ltd.
Pune, Maharashtra, India
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: https://www.insightaceanalytic.com
Follow Us on LinkedIn @ https://bit.ly/2tBXsgS
Follow Us On Facebook @ https://bit.ly/2H9jnDZ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Fragile X Syndrome Market 2027: Top Key Players Marinus pharmaceuticals, Ovid therapeutics, Kareus Therapeutics, Bellus health Inc., AMO pharmaceuticals, Eli Lilly & Company, Neuren pharmaceuticals, Anavex Life Sciences Corp., and Zynerba Pharmaceu here

News-ID: 1628470 • Views: 645

More Releases from InsightAce Analytic Pvt. Ltd.

Global Neoantigen Cancer Vaccine Market Assessment Report 2028 key player such a …
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Neoantigen Cancer Vaccine Market Assessment - Revenue (US$ Mn) Forecast Till 2028" Request for Sample Pages: https://bit.ly/2uegPR0 Neoantigen Cancer Vaccines are the vaccines which assist in boosting the immune system by using single or few several antigen. The antigens are generally consists of several peptides or proteins. Neoantigens are a mutated or a new type of antigen present only in
Global Salesforce CPQ Consulting Services Market Research Report with Analysis o …
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on “Global Salesforce CPQ Consulting Services Market Analysis – Revenue (US$ Mn) Forecast Till 2028” Request for ToC/Proposal: https://www.insightaceanalytic.com/report-details/global-salesforce-cpq-consulting-services-market-assessment/ This report is a comprehensive analysis, forecast, market dynamics and major trends report, covering key market data on the Salesforce CPQ Consulting Services Industry segments. This market research report provides market estimation and forecast for value (US$) within Salesforce CPQ
Global Salesforce CPQ Consulting Services Market Research Report with Analysis o …
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on “Global Salesforce CPQ Consulting Services Market Analysis – Revenue (US$ Mn) Forecast Till 2028” Request for ToC/Proposal: https://www.insightaceanalytic.com/report-details/global-salesforce-cpq-consulting-services-market-assessment/ This report is a comprehensive analysis, forecast, market dynamics and major trends report, covering key market data on the Salesforce CPQ Consulting Services Industry segments. This market research report provides market estimation and forecast for value (US$) within Salesforce CPQ
Global Filgrastim Biosimilars Market Research Report 2019: Industry Insights, Ma …
InsightAce Analytic new report on Filgrastim Biosimilar marketoffers a detailed evaluation of the global industry by analysing market dynamic factors including the drivers, challenges and trends in upcoming years. Also, it includes the detailed analysis of local as well as international players involved in Filgrastim Biosimilar industry. These market dynamic factors are analyzed in the report to see an overall impact on the global market revenue forecast. Filgrastim Biosimilar market-Competitive Landscape:

All 5 Releases


More Releases for Fragile

Fragile X Syndrome-Pipeline Review H2 2018
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Fragile X Syndrome-Pipeline Review, H2 2018, provides an overview of the Fragile X Syndrome (Genetic Disorders) pipeline landscape. Fragile X syndrome is a genetic condition that causes a range of developmental problems including learning disabilities and cognitive impairment. Fragile X syndrome is caused by a change in a gene called FMR1. Fragile X syndrome occurs both in male and female. Symptoms include delay
Iron Castings Market - Fragile Industry in 2025
Global Iron Castings Market: Overview Iron casting s is carried out in in a foundry, where the molten iron is put into a cast or a vessel in order to make a required shape out of it. Cast materials are in general cold setting materials or metals for example concrete, plaster, epoxy, ceramic, clay, or iron. In this the molten fluid is put to obtain a desired shapes and sizes. Iron
EpiCast Report: Fragile X Syndrome - Epidemiology Forecast to 2026
MarketResearchReports.Biz presents this most up-to-date research on "EpiCast Report: Fragile X Syndrome - Epidemiology Forecast to 2026". Fragile X syndrome (FXS) is the most frequent form of inherited intellectual disability. FXS affects both men and women and the condition is also linked to other neurological and psychiatric disorders (CDC, 2017a). FXS is caused by an abnormal expansion in the number of the trinucleotide CGG repeats located in the 5' UTR in
Fragile X Syndrome - Pipeline Review, H2 2017 : MarketResearchReports.biz
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fragile X Syndrome - Pipeline Review, H2 2017, provides an overview of the Fragile X Syndrome (Genetic Disorders) pipeline landscape. Fragile X syndrome is a genetic condition that causes a range of developmental problems including learning disabilities and cognitive impairment. Fragile X syndrome is caused by a change in a gene called FMR1. Fragile X syndrome occurs both in male and
Fragile X Syndrome Market: Industry Size, Share, Growth, Forecasts
Latest industry research report on: Fragile X Syndrome Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fragile X Syndrome - Pipeline Review, H1 2017, provides an overview of the Fragile X Syndrome (Genetic Disorders) pipeline landscape. Complete Report Details @ https://www.marketresearchreports.biz/reports/1063555/fragile-x-syndrome-pipeline-review-h1-2017-market-research-reports Gastric ulcer is a painful sore or ulcer in the lining of stomach. The most common
Fragile-x Syndrome Therapeutics Pipeline Analysis, 2017 - Patent, Designation, C …
Due to lack of awareness among people regarding genetic disorders which leads to mutations in one’s DNA, the prevalence of fragile-x syndrome is increasing, across the globe. Smoking, alcohol consumption during pregnancy and hereditary disorders are few of the primary reasons to for the increase in prevalence of fragile-x syndrome. The therapeutic pipeline of fragile-x syndrome is expected to grow more rapidly in the future on account of active involvement